Status: Not yet recruiting
Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis
A Multi-center, Double-blind, Randomized, Active-controlled, Parallel-group, Phase III Clinical Trial and Open-label Extension Study to Evaluate the Efficacy and Safety of DWP14012 for Maintenance Therapy in Patients with Healed Erosive Esophagitis
Participants needed: 420
Trial details
Phase: Phase 3Age: 19-75Biological sex: AllType: InterventionalSponsor: Daewoong Pharmaceutical Co. LTD.Updated: Aug 13, 2026
Eligibility criteria
Adult men and women aged 19 to 75 years at the time of written informed consent [+4]
Presence of heartburn or acid regurgitation within 7 days prior to Visit 2 (Rand... [+23]